← back to search

Jack Wei Chieh Tan

Novartis (Switzerland) · CH
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Medicine, Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention, and East Asia.
h-index
citations
955
works
16
NIH funding
primary concept
email

Recent publications

Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study
Clinical Chemistry 2026cited by 4position: middledoi
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050
Journal of the American College of Cardiology 2025cited by 25position: middledoi
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease
Journal of the American College of Cardiology 2025cited by 25position: middledoi
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease
JACC Asia 2025cited by 15position: middledoi
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study
European Journal of Preventive Cardiology 2025cited by 9position: middledoi
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
The Lancet Regional Health - Western Pacific 2024cited by 74position: middledoi
Variation in secondary prevention of coronary heart disease: the INTERASPIRE study
European Heart Journal 2024cited by 67position: middledoi
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
Nature Reviews Cardiology 2023cited by 76position: middledoi
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort
The Lancet Regional Health - Western Pacific 2023cited by 32position: middledoi
Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors
Frontiers in Cardiovascular Medicine 2022cited by 39position: middledoi
Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
Cardiovascular Diabetology 2021cited by 116position: middledoi
Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis
European Heart Journal - Quality of Care and Clinical Outcomes 2020cited by 36position: middledoi
Advanced analyses of computed tomography coronary angiography can help discriminate ischemic lesions
International Journal of Cardiology 2018cited by 20position: middledoi
Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography
Journal of the American College of Cardiology 2017cited by 206position: middledoi
Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey
Clinical Infectious Diseases 2017cited by 144position: middledoi
Simplified Models of Non-Invasive Fractional Flow Reserve Based on CT Images
PLoS ONE 2016cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Y. Chan · National University of Singapore3 papers (2021–2025)Andrew Fu Wah Ho · National University of Singapore2 papers (2021–2022) · 2 papers (2021–2022) · 2 papers (2023–2025)Heerajnarain Bulluck · Leeds General Infirmary2 papers (2021–2022)Tiong‐Cheng Yeo · National University of Singapore2 papers (2021–2022)Ping Chai · National University of Singapore2 papers (2021–2022)Ching-Hui Sia · National University Health System2 papers (2021–2022)Boon Wah Liew · Novartis (Switzerland)2 papers (2021–2022) · 2 papers (2021–2022) · 2 papers (2021–2022)Huili Zheng · Khoo Teck Puat Hospital2 papers (2021–2022) · 2 papers (2021–2022)Khung Keong Yeo · National University of Singapore2 papers (2016–2020)Derek J. Hausenloy · National University of Singapore2 papers (2021–2022)Junsuk Ko · National University of Singapore2 papers (2021–2022)Paul Jie Wen Tern · Novartis (Switzerland)1 papers (2020–2020)Sigrun Halvorsen · Oslo University Hospital1 papers (2023–2023)Issei Komuro · National Institute of Animal Health1 papers (2020–2020)Christopher M. Reid · Curtin University1 papers (2020–2020)